Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
06/2009
06/11/2009WO2002026930A3 Nucleic acids, proteins, and antibodies
06/11/2009US20090149635 Antibodies to human zcytor17 ligand
06/11/2009US20090149428 Methods for Assessing the Predisposition or Susceptibility to COPD
06/11/2009US20090149346 Strategies for gene expression analysis
06/11/2009US20090148945 Novel Biodegradable Elastomeric Scaffold for Tissue Engineering and Light Scattering Fingerprinting Methods for Testing the Same
06/11/2009US20090148854 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
06/11/2009US20090148839 Method for evaluating cell populations
06/11/2009EP1613724A2 Cell lines and host nucleic acid sequences related to infectious disease
06/10/2009CN101454452A Engineered proteases for affinity purification and processing of fusion proteins
06/10/2009CN100497639C Means and methods for the production of adenovirus vectors
06/10/2009CN100497616C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
06/10/2009CN100497369C Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
06/09/2009US7544786 Polynucleotide
06/09/2009US7544785 Reacitng chitin with NaOH by suspending it in a nonsaponifiable, non-aqueous, water insoluble liquid having a flash point greater than about 100 degrees C
06/09/2009US7544777 Porphorymonas gingivalis polypeptides and nucleotides
06/09/2009US7544510 Stem cells of the islets of Langerhans and their use in treating diabetes mellitus
06/09/2009US7544478 Method for screening for compounds that modulate P16 mediated regulation of NMDA receptors
06/09/2009US7544470 identifying or classifying genetic diseases characterized by genome rearrangement; mapping complex traits controlled by repeat insertion mutations in a plant or mammalian; cost effective method to identify genetic mutations and disorders
06/09/2009CA2251355C Il-6 mutein
06/04/2009WO2005017099A3 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters
06/04/2009US20090143320 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
06/04/2009US20090143232 Method for synthesising templated molecules
06/02/2009US7541454 Compounds and methods for fluorescent labeling
06/02/2009US7541335 Nogo-receptors and methods of use
05/2009
05/28/2009WO2005030927A3 Methods and compositions for in vivo inflammation monitoring
05/28/2009WO2005017112A3 Methods of inhibiting cancer growth by binding to nuclear receptors
05/28/2009US20090137738 Ladder copolymers
05/28/2009US20090136983 Target sequences for synthetic molecules
05/28/2009US20090136914 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests
05/28/2009US20090136535 useful for enhancing immune response to antigens; lack ganglioside binding activity; applicable to mucosal immunization in humans
05/27/2009EP2062977A1 Fucosyltransferase-gen
05/27/2009EP1641910A4 Glucanases, nucleic acids encoding them and methods for making and using them
05/27/2009CN100491538C Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
05/26/2009US7538209 Lactobacillus acidophillus nucleic acid sequences encoding cell surface protein homologues and uses therefore
05/26/2009US7537898 Compositions and methods of selective nucleic acid isolation
05/26/2009US7537756 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine
05/21/2009US20090131308 Splice Variants of ErbB Ligands, Compositions and Uses Thereof
05/21/2009US20090130736 Using protein denaturant and aprotic solvent to recover RNA for use in genetic analysis
05/21/2009US20090130124 Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
05/20/2009CN100489102C T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
05/19/2009US7534876 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
05/19/2009US7534569 using a polymerase extension reaction; elongation of an initial polynucleotide along a template oligonucleotide which has a 3' portion complementary to a 3' portion of the initial polynucleotide; template oligonucleotide can comprise a 3'-terminal blocker to prevent extension of the template
05/19/2009US7534437 new mutant forms of the Sm14 protein, for producing a greater production volume; providing protection against schistosome and fasciola infection
05/19/2009US7534431 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis
05/14/2009WO2005003299A3 Polynucleotides encoding novel guanylate binding proteins (gbp's)
05/14/2009US20090124002 Alpha-1d calcium channel expressed in atrium
05/14/2009US20090123922 Bead Bound Combinatorial Oligonucleoside Phosphorothioate And Phosphorodithioate Aptamer Libraries
05/12/2009US7531649 Methods that allow the identification of aptamers to receptor tyrosine kinases such as HER3 as well as specific aptamers that recognize these molecules
05/12/2009US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation
05/12/2009US7531299 Using sperm adhesion molecule 1 (SPAM 1) as tool to enhance sperm attachment to egg; in vitro fertilization
05/12/2009US7531177 Surface protein of leptospira
05/07/2009WO2005059104A3 Slc5a7 genetic markers associated with age of onset of alzheimer's disease
05/07/2009US20090117577 Methods to identify compounds useful for tumor sensitization to dna damage
05/06/2009EP1563092A4 Assays and methods based on microcompetition with a foreign polynucleotide
05/05/2009US7527950 Ability to produce L-glutamic acid, valine, threaonine, histidine or proline is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein
05/05/2009US7527790 Genetic engineered protein; screening, controlling gene expression
04/2009
04/30/2009WO2005059101A3 Novel sodium channel
04/30/2009WO2005019425A3 Heat stable variants of adenosine diphosphate glucose pyrophosphorylase
04/30/2009WO2005010169A3 High throughput or capillary-based screening for a bioactivity or biomolecule
04/30/2009WO2005010158A3 Ex vivo methods and compositions for administering a rnai agent to a subject
04/30/2009US20090111170 Nucleic acid processing methods, kits and devices
04/29/2009EP1601966B1 Methods and compositions for purification of nucleic acid from a host cell
04/29/2009CN101421300A Novel sodium channel
04/29/2009CN101418280A High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa
04/29/2009CN100482799C Regulation of quinolate phosphoribosyl transferase expression
04/29/2009CN100482795C IREN protein, its preparation and use
04/28/2009US7525013 generating transgenic plantS comprising introducing into a somatic embryo, a polynucleotide encoding dihydrodipicolinate synthase (DHPS) polypeptide, effective to render the embryo resistant to S-2-aminoethylcysteine; herbicide resistance
04/28/2009US7524674 Triple or double fusion vector harboring a Positron Emission Tomographic (PET), a bioluminescence and a fluorescence reporter gene that is imageable in living cells using a fluorescence microscope, a charge couple camera
04/28/2009US7524664 Regio- and enantioselective alkane hydroxylation with modified cytochrome P450
04/28/2009US7524656 Ability to produce L-glutamic acid, arginine or lysine is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein
04/28/2009US7524514 Three dimensional, malleable cell culture; tissue engineering; pluripotent cells
04/28/2009US7524498 Human immunomodulatory monoclonal antibodies for the treatment of cancer
04/23/2009US20090104670 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor
04/22/2009EP1567672B1 Expression profiling based on histocultures
04/22/2009CN101416059A Automated cell culture system and process
04/22/2009CN101415826A Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof
04/22/2009CN101415721A Compositions for purifying and crystallizing molecules of interest
04/21/2009US7521424 Albumin fusion proteins
04/21/2009US7521223 Expression vector comprising nucleotide sequences coding diacylglycerol acyltransferases for use in enhancing omega fatty acids production in yarrowia
04/21/2009US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors
04/16/2009WO2005056761A3 REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi
04/16/2009WO2005042727A3 Methods of organ regeneration
04/16/2009WO2005042720A3 Kahalalide-producing bacteria
04/16/2009WO2005040356A3 Mutant p53 protein and uses thereof
04/16/2009WO2005035714A3 Vaccines for cancer, autoimmune disease and infections
04/16/2009WO2005035713A3 Alternatively spliced variants of human cox1
04/16/2009WO2005021705A9 Citrus sesquiterpene synthase, methods of production and uses thereof
04/16/2009US20090099107 Methods and Compositions for Inhibition of Nuclear Factor kappaB
04/16/2009US20090098614 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA
04/16/2009DE19520398B4 Magnetisches Pigment Magnetic pigment
04/15/2009EP2048157A1 Polynucleotide encoding the rg1 polypeptide
04/15/2009CN101410531A Genetic markers for skatole metabolism
04/15/2009CN101410519A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
04/14/2009US7517530 Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency comprising administration of IGF-1 and growth hormone
04/09/2009WO2005059099A3 Human ipla2t
04/09/2009WO2005054429A3 Synthesis of the c1-c6 keto-acid synthon of the epothilones
04/09/2009WO2005044990A3 Use of differentially expressed nucleic acid sequences as biomarkers for cancer
04/09/2009WO2005044979A3 Glycosylation enzymes and systems and methods of making and using them
04/09/2009WO2005033282A3 Polyamide compositions and therapeutic methods for treatment of human papilloma virus
04/09/2009WO2005021712A3 Modified molecular beacons
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 100